Source:http://linkedlifedata.com/resource/pubmed/id/15760408
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
2005-3-11
|
pubmed:abstractText |
The aim of this pilot study was to investigate whether de novo calcineurin-inhibitor-free immunosuppression after cardiac transplantation is efficacious and can prevent post-operative renal impairment. Eight patients were treated by combining trough level adjusted sirolimus and mycophenolate mofetil; corticosteroids were given for the first 6 post-operative months only. Survival data, acute rejection episodes and adverse events with a special emphasis on renal impairment, myelosuppression, hypercholesterolemia, hypertriglyceridemia and infections, were recorded. With a follow-up of 3-12 months, patient survival was 100% and freedom from rejection 75%. The mean creatinine levels initially decreased and remained stable thereafter. A moderate myelosuppressive effect did not necessitate dose reduction of immunosuppressants, intermittently elevated cholesterol- and triglyceride levels decreased over time. Most frequent adverse events were pericardial effusions and peripheral edema. Complete abandonment of calcineurin inhibitor therapy by de novo use of the combination sirolimus/mycophenolate mofetil resulted in low rejection rate and avoidance of renal impairment, but should not be used without further evaluation of potential complications in a lager setting.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1600-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
827-31
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15760408-Adult,
pubmed-meshheading:15760408-Calcineurin,
pubmed-meshheading:15760408-Creatinine,
pubmed-meshheading:15760408-Female,
pubmed-meshheading:15760408-Graft Rejection,
pubmed-meshheading:15760408-Heart Transplantation,
pubmed-meshheading:15760408-Humans,
pubmed-meshheading:15760408-Immunosuppressive Agents,
pubmed-meshheading:15760408-Kidney,
pubmed-meshheading:15760408-Lipids,
pubmed-meshheading:15760408-Male,
pubmed-meshheading:15760408-Middle Aged,
pubmed-meshheading:15760408-Renal Insufficiency
|
pubmed:year |
2005
|
pubmed:articleTitle |
First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation.
|
pubmed:affiliation |
Department of Cardiac Surgery, University of Munich, Grosshadern Medical Center, Marchioninistrasse, Munich, Germany. bruno.meiser@hch.med.uni-muechen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|